Regis Vilchez Email

SVP Finance & Operations . BiomX

,

Location

r*****@biomx.com

Primary Email

LinkedIn

Current Roles

Employees:
100
Revenue:
$15.5M
About
BiomX is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. We discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets.   The Company?s platforms use computational and synthetic biology and cutting-edge research from Profs. Rotem Sorek, Ph.D., Eran Elinav, M.D., Ph.D., and Eran Segal, Ph.D., of The Weizmann Institute of Science; and Professor Timothy K. Lu, M.D., Ph.D., of The Massachusetts Institute of Technology. Investors in the Company include OrbiMed Israel Incubator LP, Johnson & Johnson Development Corporation Inc., Takeda Ventures, Inc., Seventure Partners, Mirae Asset Global Investments, and SBI.
BiomX Address
36 E Industrial Rd
null, null
Israel
BiomX Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.